Er-Kim Partners with Kyowa Kirin to Commercialize Palliative Care Portfolio in Eleven CEE Countries
Updated: Jun 9, 2022
Sofia, Bulgaria – May, 2022 – Er-Kim, a regional specialty pharmaceutical company, announced today the signature of an exclusive agreement with Kyowa Kirin International EMEA (Kyowa Kirin) for the distribution and sales of Kyowa Kirin’s palliative care portfolio in eleven Central and Eastern European (CEE) countries.
Under the terms of the agreement, Er-Kim will be exclusively responsible for the commercialization and distribution of Kyowa Kirin’s palliative care portfolio in eleven countries, including Albania, Bosnia & Herzegovina, Bulgaria, Croatia, Kosovo, Montenegro, Moldova, North Macedonia, Romania, and Slovenia.
Cem Zorlular, CEO of Er-Kim added; “We are thrilled by the prospect of enabling access to Kyowa Kirin’s palliative care portfolio for patients in eleven countries. We are very proud of work we have done in this space with Kyowa Kirin in the past seven years and are incredibly privileged to expand our collaboration with a partner who shares our passion in addressing patients’ unmet needs in oncology.”
About Er-Kim Pharmaceuticals
Er-Kim broadens and accelerates global patient access to innovative treatments by offering biopharmaceutical companies of all sizes flexible, sustainable, and compelling business models to commercialize their products in international markets. Over the past forty years, more than sixty global pharmaceutical companies trusted Er-Kim as their regional partner. To learn more, please visit www.er-kim.com.
Didem Yıldız – email@example.com